ArthNow Logo
ArthNow
•4 min read•
✦Reported by Business Standard

BLS Polymers zooms 8%, hits record high post Q2 nos; up 100% from IPO level

BLS Polymers zooms 8%, hits record high post Q2 nos; up 100% from IPO level
Source: Business Standard

Executive Brief • Key Highlights

Fast factual intelligence distilled for busy investors, executives, and answer bots:

  • ✓BLS Polymers shares jumped 8 percent to hit a record high of ₹303.95 on Thursday after strong Q2 results.
  • ✓The company reported a 130.63 per cent growth in profit to ₹10.54 crore.
  • ✓Since its IPO, the stock has doubled investors' money, showing a total return of 102 per cent.

Story at a Glance

Category
Indian Markets
Reported By
Business Standard
Reading Speed
4 Minute(s)
Market Focus
India Economy

Home / Markets / News / BLS Polymers zooms 8%, hits record high post Q2 nos; up 100% from IPO level

BLS Polymers zooms 8%, hits record high post Q2 nos; up 100% from IPO level

BLS Polymers, a manufacturer of multiple grades of custom-formulated polymer compounds, reported 130.63 per cent Y-o-Y growth in its PAT to ₹10.54 crore for Q2FY27, compared to ₹4.57 crore in Q2FY26.

BLS Polymers zooms 8%, hits record high post Q2 nos; up 100% from IPO level

Abhinav Ranjan New Delhi

Listen to This Article

BLS Polymers share price: Shares of newly listed BLS Polymers rallied for the third consecutive session on Thursday after the company reported strong financial results for the September quarter of FY27.

🔒
Premium Content

Unlock the Full Story with ArthNow Premium

To continue reading this complete financial story and in-depth market context, upgrade to ArthNow Premium. Enjoy unlimited access across Web and Mobile.

✓ Full Unabridged Reports✓ Executive Audio Briefs✓ 100% Ad-Free Reading
Verified Publication Source

Business Standard

Read the full, original unfiltered story directly on the publisher's portal.

Visit Original Article

This brief is for information only and is not investment advice. ArthNow is not a SEBI-registered investment adviser and does not publish buy or sell recommendations. Original reporting is credited to the publisher named above. Read our editorial policy or report an error.